fda decision tirzepatide fda shortage list tirzepatide The FDA's recent decision to remove tirzepatide from its shortage list has Compounded Tirzepatide vs Mounjaro/Zepbound: 75%

The general mean weight reduction for TZP and placebo from weeks 0 to 88 were respectively 25.3% and 9.9% (106)

Understanding what compounded tirzepatide is, how it differs from brand-name versions, and what to look for when choosing a source is critical for making an informed decision

Other related drugs, such as liraglutide (Victoza) and tirzepatide (Mounjaro, Zepbound) may cause some of the same side effects

It is a GLP-1 receptor agonist, its just not as effective, it produces an 8% weight loss, its going off patent, I believe in 2023 or 24 and when it goes off patent, I think that there will be generics to at least make that drug available at a very reasonable cost

Maintenance Dose : The maximum recommended dose for weight loss is 15 mg once a week